Search filters

Swiss Nuclides raises CHF 2.6m in Series A Financing

Swiss Nuclides AG, a developer of novel radionuclide PET tracers for the precision diagnostics, has raised CHF 2.6m.

UMB Solutions acquires ubitec

ubitec AG, a developer of innovative software solutions for digitization, was acquired by UMB Solutions AG, a leading Swiss IT services provider.

DomoSafety SA closes a Serie B financing round

DomoSafety SA, a leading company in the digital health segment, announced the successful closing of its Series B financing round.

Faveeo SA closes a Series B financing round

Faveeo SA, a Swiss start-up, announced the successful closing of its Series B financing round.

Haya Therapeutics completes CHF 18m Seed Financing Round

HAYA Therapeutics SA announced the successful closing of its CHF 18m seed round.

Oculis closes an oversubscribed USD 57m Series C financing round

Oculis S.A., a late-stage biopharmaceutical company, focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, has closed an oversubscribed USD 57m Series C financing round.

RELIEF THERAPEUTICS Holding SA to acquire Applied Pharma Research S.A.

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company, acquires Applied Pharma Research S.A., a privately held Swiss pharmaceutical company.

Sale of Mestex AG to Grünenthal

The previous owners of Mestex AG, a Swiss biotech company developing, sold their shares and stock options to the pharmaceutical company Grünenthal

"Unsere Champions" with successful market entry in Switzerland

"Unsere Champions" acquired, for the first time, various childcare facilities in the German-speaking part of Switzerland from private sellers.

First closing of EUR 130m by MTIP

Basel-based MTIP, a private equity firm focusing on digital health and connected medical device companies, has completed a first closing of EUR 130m...

You are currently offline. Some pages or content may fail to load.